Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.

Inclusion Criteria:

• Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
• Children who has official height record at least 6 months prior

Exclusion Criteria:

• Children with Epiphyseal closure